Citation Impact
Citing Papers
First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas
2016
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype
2007 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial
2013
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
2017 Standout
Breast cancer
2019 Standout
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Triple-Negative Breast Cancer
2010 Standout
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
2008 Standout
Hallmarks of 'BRCAness' in sporadic cancers
2004
BRCA1 and BRCA2: 1994 and beyond
2004
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
2008
Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons
2014
A view on drug resistance in cancer
2019 StandoutNature
Breast cancer
2016 Standout
Midwife-led continuity models versus other models of care for childbearing women
2015 Standout
Molecular subgroups of medulloblastoma
2012
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Midwife-led continuity models versus other models of care for childbearing women
2013 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
2005 StandoutNature
Medical management of brain tumors and the sequelae of treatment
2014
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer
2007
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
2016
Liver-Directed Radiotherapy for Hepatocellular Carcinoma
2016
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Molecular subgroups of medulloblastoma: the current consensus
2011
The effect of decision aids on the agreement between women’s and physicians’ decisional conflict about hormone replacement therapy
2003
Molecular mechanisms of cisplatin resistance
2011 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
The Evolving Landscape of Brain Metastasis
2018
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
2014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
The patient–doctor relationship: a synthesis of the qualitative literature on patients' perspectives
2009
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
2008 Standout
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
2014
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
2005
Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review
2015
Management of breast cancer brain metastases: A practical review
2016
Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis
2015
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Targeting autophagy in cancer
2017 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Ki67 expression in breast cancer
2016 Standout
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
2011
Local treatments for metastases of renal cell carcinoma: a systematic review
2014
Defining and Measuring Interpersonal Continuity of Care
2003
Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006
2006
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma
2015
Hepatocellular carcinoma
2022 Standout
Brain Metastases from Thyroid Carcinoma: A Retrospective Study of 21 Patients
2013
Management of glioblastoma: State of the art and future directions
2020 Standout
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 Standout
Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas
2006
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
2014
Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
2018
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ
2012 Standout
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Breast Cancer Treatment
2019 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
2012
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
2010
Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations
2009
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
2009
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes
2021
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
2009
Medical Management of Brain Metastases and Leptomeningeal Disease in Patients with Breast Carcinoma
2018
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Works of David Roberge being referenced
Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience
2016
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
2009
Interobserver Variability in Target Definition for Hepatocellular Carcinoma With and Without Portal Vein Thrombus: Radiation Therapy Oncology Group Consensus Guidelines
2014
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
2013
The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy
2012
Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease
2016
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
2003
Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma
2010
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
2013
Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma
2010
Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy
2015
Loyalty to the regular care provider: patients' and physicians' views
2001
Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers
2010
Patient perception of quality following a visit to a doctor in a primary care unit
2000